BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed IMCR catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:d192934d53fcab58ea22@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20261130
DTEND;VALUE=DATE:20261201
SUMMARY:IMCR P1/P2 readout (est.): Phase 1/2 Study of IMC-R117C in Selected
  Advanced Cancers
DESCRIPTION:Phase 1/2 Study of IMC-R117C in Selected Advanced Cancers\nNCT0
 6840119 | PHASE1/PHASE2 | RECRUITING | sponsor: Immunocore Ltd\nPrimary co
 mpletion date (ESTIMATED)\; top-line results usually follow later.\nTicker
  IMCR (confidence 0.9)\nSource: https://clinicaltrials.gov/study/NCT068401
 19\nScheduling/reference data from public records\; dates can move. Not in
 vestment\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT06840119
CATEGORIES:readout,ESTIMATED
END:VEVENT
END:VCALENDAR
